Cryptococcus neoformans-Cryptococcus gattii Species Complex: an International Study of Wild-Type Susceptibility Endpoint Distributions and Epidemiological Cutoff Values for Amphotericin B and Flucytosine

Clinical breakpoints (CBPs) are not available for the Cryptococcus neoformans-Cryptococcus gattii species complex. MIC distributions were constructed for the wild type (WT) to establish epidemiologic cutoff values (ECVs) for C. neoformans and C. gattii versus amphotericin B and flucytosine. A total...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Espinel-Ingroff, A., Chowdhary, A., Cuenca-Estrella, M., Fothergill, A., Fuller, J., Hagen, F., Govender, N., Guarro, J., Johnson, E., Lass-Flörl, C., Lockhart, S. R., Martins, M. A., Meis, J. F., Melhem, M. S. C., Ostrosky-Zeichner, L., Pelaez, T., Pfaller, M. A., Schell, W. A., Trilles, L., Kidd, S., Turnidge, J.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society for Microbiology 2012
Aiheet:
Epidemiology and Surveillance
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3370763/
https://ncbi.nlm.nih.gov/pubmed/22391546
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.06252-11
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia